ICAP
BLUE

Independence Capital Asset Partners’s bluebird bio BLUE Stock Holding History

Independence Capital Asset Partners’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-13,899
Closed -$16.5M – 83
2014
Q4 		$16.5M Buy
+13,899
New +$9.29M 2.28% 17

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Independence Capital Asset Partners's BLUE Position: Q1 2015 in Review

Independence Capital Asset Partners sold out of bluebird bio (BLUE) in Q1 2015, closing a stake of 13,899 shares — an estimated $16.5M sold.

Independence Capital Asset Partners first reported a position in BLUE in Q4 2014 and held it in 1 quarter. The position peaked at $16.5M in Q4 2014. 210 funds tracked by Wall St. Rank hold BLUE as of Q1 2015.

  • Independence Capital Asset Partners reported no remaining bluebird bio position as of Q1 2015 after selling out during the quarter.
  • Independence Capital Asset Partners sold 13,899 bluebird bio shares in Q1 2015, an estimated $16.5M.
  • Independence Capital Asset Partners first reported a position in bluebird bio in Q4 2014 and held it in 1 quarter.
  • Independence Capital Asset Partners's bluebird bio position peaked at $16.5M in Q4 2014.
  • 210 funds tracked by Wall St. Rank held bluebird bio as of Q1 2015.

Based on Independence Capital Asset Partners's 13F filing for Q1 2015, filed 14 May 2015.